Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

42.15
-0.2300-0.54%
Post-market: 42.150.00000.00%18:01 EDT
Volume:879.30K
Turnover:37.19M
Market Cap:6.71B
PE:-14.06
High:42.81
Open:42.35
Low:42.12
Close:42.38
Loading ...
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Jan 16, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Dec 23, 2019

Major Issues Report

Current report, items 1.01, 2.03, 3.02, and 9.01
Dec 20, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 13, 2019

Major Issues Report

Current report, items 2.03, 3.02, and 8.01
Dec 12, 2019

Major Issues Report

Current report, items 2.03, 3.02, 8.01, and 9.01
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 30, 2019

Major Issues Report

Current report, item 1.02
Aug 08, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01